Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.53 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.53 |
| ▸ | FAAH | O00519 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
| ▸ | CNR1 | P21554 | 1/20 | 0.42 |
| ▸ | CNR2 | P34972 | 1/20 | 0.42 |
| ▸ | PRKCA | P17252 | 4/20 | 0.42 |
| ▸ | PRKCE | Q02156 | 2/20 | 0.42 |
| ▸ | PRKCQ | Q04759 | 2/20 | 0.42 |
| ▸ | PRKCD | Q05655 | 2/20 | 0.42 |
| ▸ | ACE | P12821 | 1/20 | 0.41 |
| ▸ | MGLL | Q99685 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL538145 | 0.86 | PRKCA (0.60) | MAPTMAPK1ALDH1A1PRKCAPRKCE | |
| SCHEMBL13901278 | 0.85 | MAPT (0.61) | MAPTMAPK1FAAHALDH1A1HPGD | |
| SCHEMBL25272484 | 0.81 | ACE (0.41) | MAPTMAPK1PRKCAPRKCEPRKCQ | |
| SCHEMBL560043 | 0.80 | MAPT (0.47) | MAPTMAPK1FAAHALDH1A1HPGD | |
| SCHEMBL99261 | 0.77 | ALDH1A1 (0.56) | ALDH1A1PRKCAPRKCEPRKCQPRKCD | |
| SCHEMBL76959 | 0.76 | MAPT (0.70) | MAPTMAPK1FAAHALDH1A1HPGD | |
| SCHEMBL8843449 | 0.76 | MAPT (0.64) | MAPTMAPK1FAAHALDH1A1HPGD | |
| SCHEMBL542358 | 0.76 | MAPT (0.53) | MAPTMAPK1FAAHALDH1A1HPGD | |
| SCHEMBL25475240 | 0.76 | ACE (0.38) | MAPTMAPK1ALDH1A1PRKCAPRKCE | |
| SCHEMBL29225303 | 0.75 | ACE (0.43) | ACE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 84 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12458576-B2 | Method for removing color from artificially colored hair | L'OREAL (FR) | 2025-11-04 | — | — | US | claimed |
| US-20240122833-A1 | METHOD FOR REMOVING COLOR FROM ARTIFICIALLY COLORED HAIR | L'OREAL (FR) | 2024-04-18 | — | — | US | claimed |
| EP-3506877-B1 | CONCENTRATE FOR KERATIN FIBER TREATMENT COMPOSITIONS | LABORATOIRE BIOSTHETIQUE KOSMETIK GMBH & CO KG (DE) | 2024-03-27 | — | — | EP | claimed |
| US-20230355496-A1 | CONCENTRATE FOR KERATIN FIBER TREATMENT COMPOSITIONS | LABORATOIRE BIOSTHETIQUE KOSMETIK GMBH & CO. KG (DE) | 2023-11-09 | — | — | US | claimed |
| EP-3773439-A1 | HAIR TREATMENT COMPOSITIONS COMPRISING REDUCING AGENTS | L'OREAL (FR) | 2021-02-17 | — | — | EP | claimed |
| US-20210030651-A1 | HAIR TREATMENT COMPOSITIONS COMPRISING REDUCING AGENTS | L'OREAL (FR) | 2021-02-04 | — | — | US | claimed |
| CN-111936111-A | Hair treatment composition comprising a reducing agent | 欧莱雅 | 2020-11-13 | — | — | CN | claimed |
| WO-2020220098-A1 | STABLE HAIR TREATMENT COMPOSITIONS COMPRISING THIOL-BASED REDUCING AGENTS AND CHELATING AGENTS | L'OREAL (FR) | 2020-11-05 | — | — | WO | claimed |
| WO-2020061659-A1 | STABLE HAIR TREATMENT COMPOSITIONS COMPRISING THIOL-BASED REDUCING AGENTS | L'OREAL (FR) | 2020-04-02 | — | — | WO | claimed |
| WO-2019195900-A1 | HAIR TREATMENT COMPOSITIONS COMPRISING REDUCING AGENTS | L'OREAL (FR) | 2019-10-17 | — | — | WO | claimed |
| WO-2019195901-A1 | HAIR TREATMENT COMPOSITIONS COMPRISING REDUCING AGENTS | L'OREAL (FR) | 2019-10-17 | — | — | WO | claimed |
| WO-2019197852-A1 | HAIR TREATMENT COMPOSITIONS COMPRISING REDUCING AGENTS | L'OREAL (FR) | 2019-10-17 | — | — | WO | claimed |
| EP-3506877-A1 | CONCENTRATE FOR KERATIN FIBER TREATMENT COMPOSITIONS | Laboratoire Biosthetique Kosmetik GmbH&Co. KG (DE) | 2019-07-10 | — | — | EP | claimed |
| US-20190201306-A1 | CONCENTRATE FOR KERATIN FIBER TREATMENT COMPOSITIONS | LABORATORIE BIOSTHETIQUE KOSMETIK GMBH & CO. KG (DE) | 2019-07-04 | — | — | US | claimed |
| WO-2018042228-A1 | CONCENTRATE FOR KERATIN FIBER TREATMENT COMPOSITIONS | LABORATOIRE BIOSTHETIQUE KOSMETIK GMBH & CO. KG (DE) | 2018-03-08 | — | — | WO | claimed |
| EP-3893834-B1 | STRAIGHTENING PROCESS FOR KERATIN FIBERS | OREAL (FR) | 2026-04-29 | — | — | EP | disclosed |
| US-12491146-B1 | Skin brightening compositions with thiopyridinone compound | L'OREAL (FR) | 2025-12-09 | — | — | US | disclosed |
| EP-2568848-A1 | HAIR TREATMENT METHOD | L'Oréal (FR) | 2013-03-20 | — | — | EP | disclosed |
| WO-2011141882-A1 | HAIR TREATMENT METHOD | L'OREAL (FR) | 2011-11-17 | — | — | WO | disclosed |
| WO-2011089985-A1 | COSMETIC COMPOSITION FOR KERATIN FIBERS | L'OREAL (FR) | 2011-07-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12458576-B2 | Method for removing color from artificially colored hair | TYR, COXFA4L2, CAT | MAPT 4298/4885MAPK1 2554/4885FAAH 4217/4885 |
| US-20210030651-A1 | HAIR TREATMENT COMPOSITIONS COMPRISING REDUCING AGENTS | TST, DSG1, TYR | MAPT 1931/4885MAPK1 3565/4885FAAH 3646/4885 |
| US-20230355496-A1 | CONCENTRATE FOR KERATIN FIBER TREATMENT COMPOSITIONS | KRT18, CUTA, CRYAA | MAPT 226/4885MAPK1 2150/4885FAAH 3589/4885 |
| US-12491146-B1 | Skin brightening compositions with thiopyridinone compound | GLMN, GNMT, GLA | MAPT 2938/4885MAPK1 3653/4885FAAH 4273/4885 |
| US-20240122833-A1 | METHOD FOR REMOVING COLOR FROM ARTIFICIALLY COLORED HAIR | TYR, COXFA4L2, CAT | MAPT 4298/4885MAPK1 2554/4885FAAH 4217/4885 |
| US-20190201306-A1 | CONCENTRATE FOR KERATIN FIBER TREATMENT COMPOSITIONS | KRT18, CUTA, CRYAA | MAPT 226/4885MAPK1 2150/4885FAAH 3589/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.